Delivery Order SPE2DB20D2104-SPE2DB25FMPKX

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,250 units of the diabetes medication Jardiance 10 mg tablets. The contract has a firm fixed price of $11,866.04 and a completion date of May 15, 2025. The contract is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a substantial...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,383.59, is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,369.07, is for the delivery of 4,568,077,683 units of the diabetes medication Jardiance 10 mg tablets. The contract has an ultimate completion date of April 30, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,546.27, is for the delivery of 4,567,826,544 units of the diabetes medication Jardiance 10 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,057,960 units of the diabetes medication Jardiance 10 mg tablets in 90-count packages. The contract has a firm fixed price of $2,334.45 and a completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,255.95 fixed-price contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of April 21, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,931.70, is for the delivery of 4,567,874,185 units of the diabetes medication Jardiance 10 mg tablets. The award has an ultimate completion date of April 11, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,337.68 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,145.46 firm-fixed-price contract is for the delivery of 4,568,175,187 units of the diabetes medication Jardiance 25 mg tablets. The contract has a period of performance through May 8, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,033.73 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets, a diabetes medication. The ultimate completion date is February 28, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMPKX
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,690.91, is for the delivery of the diabetes medication Jardiance 10 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/25/25, 11:10 AM